
17
PROBABLE BENEFITS
You may get help from the NeuRx DPS
®
because in a study:
The patients who used the NeuRx DPS
®
plus non-invasive ventilation (NIV)
survived 16 months longer (on average) than patients who just used NIV. This
16 month time frame is from the time of diagnosis. Survival time was measured
until death or the need for a full time ventilator and a tube in the throat
(tracheostomy). The patients who just used NIV were similar patients in a
different study.
The patients who used the NeuRx DPS
®
plus NIV survived 9 months longer (on
average) than patients who just used NIV. This is from the time they started
using NIV.
Some patients had a feeding tube placed with the NeuRx DPS
®
. All of these
patients survived past 30 days. Normally, 2 to 25 patients out of 100 (up to a
fourth of all patients) would not survive this long.
Some patients could not get used to or were unable to use NIV but used the
NeuRx DPS
®
. They survived an average of 16 months after getting the NeuRx
DPS
®
.
Some patients had their sleep tested after using the NeuRx DPS
®
for 4 months.
They tended to have better sleep than before they received NeuRx DPS
®
.
ADDITIONAL INFORMATION
Another study was done after the Food and Drug Administration approved the NeuRx
DPS
®
. The “post-approval study” involved 60 patients at 10 hospitals in the U.S. The
study results are in a report called the “Post-Approval Clinical Study Summary”
(document 77-0088) available from your doctor or Synapse Biomedical, Inc. (To
request a copy, call Synapse Biomedical Customer Service at 1-440-774-2488
extension 137 or email [email protected].)
ALTERNATIVE PROCEDURES AND
TREATMENTS
Other breathing treatments exist for patients with ALS. These include non-invasive
ventilation through a mask or invasive ventilation with a tube through the throat.
Non-invasive ventilation (NIV).
The common device used for NIV is a bilevel or
continuous positive airway pressure machine. These supply air to the mouth or nose.
The choice of mask depends on fit, air leaks, looks, and claustrophobic concerns. A
number of current papers show NIV may help patients with ALS. Current treatment
Содержание NeuRx
Страница 27: ...27 Figure 13 Replacing the disposable battery ...
Страница 46: ...46 ...
Страница 47: ...47 ...